SCHEMBL5208748

SCHEMBL5208748

CC(C)C[C@H](NC(=O)Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)O)C(C)C

nearest known ligand 0.49

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CTSD P07339 3/20 0.49
CTSE P14091 3/20 0.49
CALCRL Q16602 1/20 0.47
ACE P12821 8/20 0.47
ACE2 Q9BYF1 4/20 0.47
PSEN1 P49768 1/20 0.46
PSEN2 P49810 1/20 0.46
APH1B Q8WW43 1/20 0.46
NCSTN Q92542 1/20 0.46
APH1A Q96BI3 1/20 0.46
PSENEN Q9NZ42 1/20 0.46
LTA4H P09960 2/20 0.46
CMA1 P23946 2/20 0.45
BACE1 P56817 2/20 0.45
ITGB1 P05556 1/20 0.45
ITGA4 P13612 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8334047 0.93 CALCRL (0.49) CTSDCTSECALCRLPSEN1PSEN2
SCHEMBL7411063 0.91 ACE (0.56) ACEACE2LTA4H
SCHEMBL8060131 0.91 ACE (0.56) ACEACE2LTA4H
SCHEMBL1223367 0.88 ITGB1 (0.64) ITGB1ITGA4
SCHEMBL2195410 0.85 ACE (0.50) CALCRLACEACE2LTA4H
SCHEMBL15251858 0.84 MEN1 (0.57) ACEACE2LTA4HITGB1ITGA4
SCHEMBL15251857 0.84 MEN1 (0.57) ACEACE2LTA4HITGB1ITGA4
SCHEMBL20484735 0.84 CCR1 (0.56) ACEACE2LTA4HCMA1
SCHEMBL18619612 0.84 CCR1 (0.56) ACEACE2LTA4HCMA1
SCHEMBL7419554 0.84 REN (0.54) CTSDCTSEACEACE2BACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0914605-B1 MOLECULAR MODEL FOR VLA-4 INHIBITORS BIOGEN IDEC INC (US) 2007-05-30 EP disclosed
US-6552216-B1 Cell adhesion inhibitors; suppressing or preventing integrin very late antigen-4 binding to its ligands BIOGEN, INC. 2003-04-22 US disclosed